Treatment of lung fibrosis : IND pharmacology and toxicology

Ended Project Grant Awarded Last action

Award ID
R44HL147724
Recipient
Awarding agency
Obligated
$1,551,949

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment Treatment of lung fibrosis : IND pharmacology and toxicology - activation of lung myofibroblasts (LMF) of different origins is responsible for the development… $0
Amendment $1,326,982
Original award $224,967

Quick answers

Who received award R44HL147724?

R44HL147724 was awarded to Xfibra, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 1, 2019.

How much is award R44HL147724 worth?

$1,551,949 has been obligated on R44HL147724.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award